Back to mobile site

AbbVie (ABBV) Plans Pipeline Update at R&D Day Event; Includes IMBRUVICA, ABT-484 Data

June 3, 2016 8:12 AM EDT Send to a Friend
At an R&D Day meeting today for the investment community, AbbVie (NYSE: ABBV) will present an overview of its innovative ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE

Member Login